Market Overview

Morning Market Movers

Share:
Related CYTR
CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)
This Is A Near-Term Driver At CytRX
Related DM
Earnings Scheduled For February 6, 2015
Dominion Agrees To Acquire Carolina Gas Transmission
Morgan Stanley prefers Dominion Midstream among dropdown MLPs (Seeking Alpha)

CytRx (NASDAQ: CYTR) rose 29.55% to 2.85 after the company reported that aldoxorubicin demonstrated statistically significant efficacy in the treatment of rapidly growing human brain cancer brains animals.

The Dolan Company (NYSE: DM) shares jumped 16.67% to $2.07 after the company announced its plans to sell two NDeX businesses.

Ambient (NASDAQ: AMBT) jumped 9.79% to $3.14 after the company reported that it has been awarded contract by Consolidated Edison.

WD-40 Company (NASDAQ: WDFC) moved up 8.71% to $62.67 on upbeat FQ3 earnings.

Posted-In: Morning Market MoversNews Intraday Update Markets

 

Related Articles (CYTR + AMBT)

Around the Web, We're Loving...